Related Experiment Video
Updated: Dec 18, 2025

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
Published on: June 13, 2025
The upside of being a digital pharma player
Alexander Schuhmacher1, Alexander Gatto2, Markus Hinder3
1Reutlingen University, Alteburgstrasse 150, DE-72762 Reutlingen, Germany.
Artificial intelligence (AI) is in an early mature phase in pharmaceutical research and development (R&D). Investing in digital transformation is worthwhile for pharmaceutical companies to become leaders in the field.
Area of Science:
- Pharmaceutical R&D
- Digital Transformation
- Artificial Intelligence
Background:
- The integration of artificial intelligence (AI) into pharmaceutical research and development (R&D) is rapidly evolving.
- Understanding the current state and future potential of AI in this sector is crucial for strategic investment and innovation.
Purpose of the Study:
- To investigate the current status of AI adoption in pharmaceutical R&D.
- To analyze the risks and rewards associated with digital R&D strategies.
- To provide insights into the 'digital pharma player' landscape.
Main Methods:
- A mixed-methods approach combining qualitative and quantitative analysis.
- Examination of annual company reports, investor relations information, patent applications, and scientific publications.
- Data collected from 21 pharmaceutical companies spanning the years 2014 to 2019.
Main Results:
- The pharmaceutical industry is currently in an 'early mature' phase of AI utilization in R&D.
- Analysis indicates a significant return on investment for companies embracing digital R&D.
- Despite necessary management efforts, AI integration presents a worthwhile strategic direction.
Conclusions:
- Pharmaceutical R&D is progressing towards advanced AI integration.
- Strategic investment in digital capabilities is essential for future competitiveness.
- The findings support the transition towards becoming a 'digital pharma player'.
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Discovery: Overview
Biopharmaceutics and Pharmacokinetics: Overview
Prodrugs
Prodrugs help overcome...

